{"content":"<li class=\"n-box-item date-title\" data-end=\"1456721999\" data-start=\"1456635600\" data-txt=\"Sunday, December 22, 2019\">Sunday, February 28, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3146796\" data-ts=\"1456715805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3146796-pearson-returns-to-valeant-ceo-ingram-chairman-shares-down-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pearson returns to Valeant as CEO, Ingram Chairman; shares down 8% premarket</a></h4><ul>\n<li>His tussle with pneumonia behind him, J. Michael Pearson <a href=\"http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-management-and-business-update-300227438.html\" target=\"_blank\">returns </a>to Valeant Pharmaceuticals (VRX) as CEO. Interim chief Howard Schiller will transition out but will continue to serve as a member of the board of directors.</li>\n<li>The company has separated the roles of Chairman and CEO with Robert Ingram assuming the role of Chairman.</li>\n<li>Tomorrow morning's (unaudited) earnings call will be reschedule. Guidance withdrawn.</li>\n<li>Separately, the company has received notice that Actavis has filed an abbreviated New Drug Application (ANDA) seeking clearance of a generic version of Salix Pharmaceuticals' <a href=\"https://www.xifaxan.com/\" target=\"_blank\">Xifaxan </a>(rifaximin) 550 mg tablets. It intends to vigorously defend its IP rights.</li>\n<li>Valeant completed its $11B takeover of Salix in March 2015.</li>\n<li>\n<strong>Update</strong>: VRX down <font color=\"red\">8%</font> premarket on increased volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3146796\" data-linked=\"Pearson returns to Valeant as CEO, Ingram Chairman; shares down 8% premarket\" data-tweet=\"$BHC - Pearson returns to Valeant as CEO, Ingram Chairman; shares down 8% premarket https://seekingalpha.com/news/3146796-pearson-returns-to-valeant-ceo-ingram-chairman-shares-down-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3146796-pearson-returns-to-valeant-ceo-ingram-chairman-shares-down-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":1,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}